FDA Advisory: Do Not Purchase SLIMDIA Revolution Diet Supplement


FDA Advisory: Do Not Purchase SLIMDIA Revolution Diet Supplement The U.S. Food and Drug Administration (FDA) just issued an advisory urging consumers not to purchase or use SLIMDIA Revolution, a product sold as a weight loss aid. Laboratory analysis revealed that the product contains sibutramine, a controlled substance that can pose health risks to users.

Sibutramine can substantially increase blood pressure and/or pulse rate in some people and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

The FDA advises consumers to stop using SLIMDIA Revolution immediately and throw away any remaining product. Anyone who experiences negative side effects from the product should contact a health care professional right away.

The FDA pointed out that there is a growing trend for hidden drugs and chemical ingredients in dietary supplements and “conventional” foods; supplements are typically marketed for weight loss, body building, and sexual enhancement and some are promoted as “all natural.”  FDA urges consumers to be cautious when purchasing supplements, especially those for weight loss.

Consumers and health care providers are encouraged to report adverse side effects related to supplement use to the MedWatch Safety Information and Adverse Event Reporting Program: Online at www.fda.gov/MedWatch/report.htm; by mail or fax, download the form or call 1.800.332.1088, toll-free, to request a copy of the pre-addressed form. Reports can be mailed to the FDA or submitted by toll-free fax to 1.800.FDA.0178.